Category:



  • 21Jul

    MOSCOW and NEW YORK, July 21 /PRNewswire-FirstCall/ — Open Joint Stock
    Company “Vimpel-Communications” (”VimpelCom” or the “Company”) (NYSE: VIP)
    announced today that it has acquired a 90% stake in the Cambodian company
    Sotelco, which holds a GSM 900/1800 license and related frequencies for the
    territory of Cambodia. The transaction was made through the purchase of 90% of
    Sotelco’s parent company, Atlas Trade Limited, for US$28 million from
    VimpelCom’s largest shareholder Altimo. The remaining 10% of Atlas will stay
    with a local partner, a Cambodian entrepreneur. VimpelCom has also acquired a
    call option to purchase the 10% interest of the local partner for market value
    at the date of exercise of the option.

    Alexander Izosimov, CEO of VimpelCom, said, “We are very happy to announce
    the next significant step in implementation of our international expansion
    strategy. The Cambodian mobile market offers attractive growth potential, as
    the country has a population of 14 million people and a low mobile penetration
    estimated at around 18%. Cambodian market entry is an important part of
    VimpelCom’s international expansion strategy particularly within a South-East
    Asian cluster of operations started by our entry to the Vietnamese mobile
    market. We foresee an impressive growth potential within the South-East Asian
    region and cluster synergies”.

    This press release contains “forward-looking statements”, as the phrase is
    defined in Section 27A of the Securities Act and Section 21E of the Exchange
    Act. These statements relate to the anticipated growth and synergy
    opportunities in the South-East Asian region. Actual results may differ
    materially from those described in such forward-looking statements as a result
    of various factors, including unforeseen developments in competition, or
    current or future changes in the political, economic and social environment or
    current or future regulation of the Cambodian, South-East Asian and Russian
    telecommunications industries. Additional information concerning factors that
    could cause results to differ materially from those in the forward-looking
    statements is contained in VimpelCom’s public filings with the SEC, including
    VimpelCom’s annual report on Form 20-F for the year ended December 31, 2007
    and other public filings made by the Company with the United States Securities
    and Exchange Commission, which risk factors are incorporated herein by
    reference. VimpelCom disclaims any obligation to update developments of these
    risk factors or to announce publicly any revision to any of the forward-
    looking statements contained in this press release, or to make corrections to
    reflect future events or developments.

    SOURCE Vimpel-Communications

  • 05May

    CHICAGO, May 5 /PRNewswire/ — The Cambodia Tribunal Monitor Web site
    today posted exclusive video interviews by TV journalist, producer and former
    CBS news anchor Bill Kurtis with the last three surviving prosecutors of
    post-World War II trials held in Nuremberg, Germany about their perspective on
    the upcoming Cambodia Tribunal. Senior officials of the Khmer Rouge regime are
    expected to be tried over the next several years for atrocity crimes in
    Cambodia during their 1975-79 rule. The pre-trial hearings of some of the
    regime leaders are currently underway.

    Kurtis interviewed prosecutors Ben Ferencz, Henry King and Whitney Harris,
    asking them to reflect on the significance of the Nuremberg trials on
    international law, what lessons we learned, how far we’ve come and what advice
    they have for the Cambodia Tribunal currently underway in Phnom Penh.

    Kurtis, with the consortium responsible for the Cambodia Tribunal Monitor
    Web site, posted these exclusive interviews with the surviving Nuremberg
    prosecutors on the Web site in an effort to raise awareness about the need to
    punish war crimes and crimes against humanity, no matter how long ago those
    crimes were committed.

    Speaking about the significance of interviewing the Nuremberg prosecutors,
    Kurtis said, “These are the voices of history speaking. They provide an
    important historical context and precedent from the post-World War II era that
    can be applied to today’s tribunal in Cambodia. I thought it was especially
    important to draw from their experience and hear their perspective, as their
    insights will inform the trials — and procedures of those trials — for
    today’s alleged war criminals.”

    When Kurtis asked if it is still worth it for Cambodia to have a tribunal
    after 30 years since the crimes were committed, former prosecutor Ben Ferencz
    said, “Of course it’s still worth it. Because it tells the people of Cambodia,
    we have not forgotten … And we are trying, within the limits of our
    capacity, to recognize that what happened to you and your people and your
    loved ones and the victims was a crime, it was an outrage, and we will never
    tolerate that as an acceptable human behavior.”

    Henry King told Kurtis that he would offer the following advice to the
    Cambodia Tribunal, “Take the long view. Be persistent. Never give up. We
    didn’t ever give up at Nuremberg … Think of future generations … because
    the weapons of destruction are becoming so violent that we’ll destroy
    ourselves if we don’t have a rule of law in the world.”

    From April 1975 to January 1979, an estimated 1.7 million Cambodian
    citizens died under the Khmer Rouge regime. After nearly 10 years of
    negotiations, this special war crimes tribunal has commenced. The
    Extraordinary Chambers in the Courts of Cambodia (ECCC), as the special
    Cambodian court is formally known, will oversee the proceedings and is a joint
    partnership of the United Nations and the Royal Government of Cambodia.

    Video and transcripts in English are now posted on
    http://www.CambodiaTribunalMonitor.org. The media will be notified when French
    voiceovers of the video and French transcripts of the interviews are available
    in the coming weeks.

    Biographies of Nuremberg Prosecutors:

    Benjamin Berell Ferencz: Ferencz is a graduate of Harvard Law School.
    Following the Nuremberg trials, Ferencz became a vocal advocate of the
    establishment of an international rule of law and of the International
    Criminal Court. From 1985 to 1996, he was Adjunct Professor of International
    Law at Pace University.

    Henry T. King, Jr.: King is a legal practitioner and an academic writer.
    King received his B.A. degree in 1941 from Yale College, and his LL.B. in 1943
    from Yale Law School (1943). Following his service at Nuremberg, King had a
    long career as counsel for several corporations, including the TRW
    Corporation. A former chairman of the American Bar Association’s Section of
    International Law and Practice, he served on the ABA’s special task force on
    war crimes in the former Yugoslavia and was the U.S. chairman of a joint
    working group, organized by the American, Canadian, and Mexican bar
    associations, on the settlement of international disputes. Currently, King
    teaches International Arbitration and is U.S. director of the Canada-U.S. Law
    Institute.

    Whitney R. Harris: Harris is author of Tyranny on Trial (1954), a major
    book about the Nuremberg Trials. In recent years he generously funded the
    establishment of The Whitney R. Harris Institute for Global Legal Studies at
    Washington University School of Law in St. Louis, bringing together experts
    from around the world to expand understanding of real-world issues and prepare
    lawyers for the professional challenges of the 21st Century. In addition to
    teaching law during his post-Nuremberg career, Harris was director of the
    Hoover Commission’s Legal Services Task Force; served as the first Executive
    Director of the American Bar Association; and was Solicitor General of
    Southwestern Bell Telephone Company in St. Louis where he practiced law until
    his retirement. In 1998, Harris was a non-governmental delegate to the United
    Nations-sponsored conference that resulted in the Rome Statute of the
    International Criminal Court.

    Background on the Cambodia Tribunal Monitor Web site:

    The Cambodia Tribunal Monitor Web site is the leading independent source
    of news and information on the upcoming trials of senior officials of the
    Khmer Rouge regime for atrocity crimes. The Web site posts timely news updates
    and guest commentaries by leading international experts on the recent history
    of Cambodia, politics, human rights and international law. It also provides
    background information on the history of the Khmer Rouge and ECCC and
    important resources such as court documents and bibliographies of scholarly
    articles and books. Complete videotaped trial footage will be available
    throughout the court proceedings.

    The Cambodia Tribunal Monitor was developed by a consortium of academic,
    philanthropic and non-profit organizations committed to providing public
    access to the tribunal and open discussion throughout the judicial process.
    The academic manager and sponsor of the site is Northwestern University School
    of Law’s Center for International Human Rights, joined by co-sponsors
    Documentation Center of Cambodia and the Illinois Holocaust Museum and
    Education Center. The prime sponsor of the site is the J.B. and M.K. Pritzker
    Family Foundation.

    The Web site was conceived by Illinois State Senator Jeff Schoenberg, a
    Chicago-area legislator who also advises the Pritzker family on its
    philanthropy. In January 2007, Schoenberg participated in a trip sponsored by
    Build Cambodia, a U.S. based not-for-profit organization dedicated to helping
    Cambodians build their lives and society. As a result of the experience,
    Schoenberg enlisted the support of the aforementioned sponsors, and with their
    assistance the Cambodia Tribunal Monitor was created.

    SOURCE Cambodia Tribunal Monitor

  • 03Apr

    TUSTIN, Calif., April 3, 2008 /PRNewswire-FirstCall/ — AMDL, Inc.
    (Amex: ADL), headquartered in Tustin, California, with operations in Shenzhen,
    Jiangxi, and Jilin, China, is a vertically integrated specialty pharmaceutical
    company. In combination with its subsidiary Jade Pharmaceutical Inc. (”JPI”),
    AMDL engages in the research, development, manufacture, and marketing of
    diagnostic products. Today, AMDL announced that it has entered into an
    exclusive sublicense (subject to certain terms and conditions) agreement with
    MyGene International, Inc. (”MGI,” USA) for the MyGene HPV Chip Kit, a
    diagnostic product for in-vitro genotype testing in women with the Human
    Papilloma Virus (HPV). The agreement between MGI and AMDL is an exclusive
    sublicense to use the patents, trademark, and technology in manufacturing,
    promoting, marketing, distributing, and selling the MyGene HPV Test Kit in the
    countries of China (including Hong Kong), Taiwan, Singapore, Malaysia,
    Thailand, Cambodia, and Vietnam. MGI owns an exclusive worldwide license (with
    rights to sublicense) for the MyGene HPV Test Kit (excluding Korea).

    HPV is the most common sexually transmitted infection. Globally there are
    approximately 330 million women presently infected with HPV, with 70% of
    existing infections in Asian populations. The virus infects the skin and
    mucous membranes. There are more than 30 important HPV types that can infect
    the genital areas of men and women, including the skin of the penis, vulva
    (area outside the vagina), and anus, and the linings of the vagina, cervix,
    and rectum. Most people who become infected with certain types of HPV do not
    even know they have it. Cervical cancer, in which malignant cells form in the
    tissue of the cervix, is third leading cancer in women and the second leading
    cause of cancer deaths in women worldwide. It is well known that certain HPV
    types are the primary cause of cervical cancer. If HPV infection is detected
    early, cervical cancer could be preventable. Early diagnosis of HPV infection,
    which could lead to cervical cancer, is recommended for every woman.

    According to recent clinical trial assessments, it was reported in Medical
    News Today that the global market for HPV testing is projected to be
    $250 million in 2008, with the total available market valued at $1 billion.
    There are more than 10 million HPV tests being performed annually in the
    United States alone, with only 28% market penetration. According to the 2007
    CIA Factbook, in China there are approximately 455 million women between the
    ages of 15 and 64 years old. In China alone, at an extremely conservative
    estimate of 1 million possible patients, with HPV screening at a cost of
    approximately $50, there is a $50 million annual market potential for HPV
    testing in China. Estimates indicate that HPV testing in China could grow from
    approximately 16 million tests in 2009 to over 25 million by 2025.

    Mr. Gary Dreher, CEO of AMDL, noted that “this HPV Diagnostic Test Kit is
    anticipated to become a major product for the Company. This sublicense
    agreement demonstrates AMDL’s capability to in-license state of the art
    diagnostic products that can gain swift regulatory approval and market
    acceptance.” Dr. Tyler McCabe, President and CEO of MGI indicated, “In China
    alone, with skillful effort, substantial sales potential could be realized
    within a few years. MGI is excited about the potential of this relationship,
    due to AMDL’s infrastructure in China and certain Asian countries, and we look
    forward to working together to enter this large market.”

    About Jade Pharmaceutical: JPI has access to the fastest growing
    pharmaceutical and consumer market in the world: China. AMDL, through its
    subsidiaries, JPI currently manufactures large volume injection fluids,
    tablets and other related products, holding licenses for 133 products. It also
    manufactures 107 generic, over the counter and supplemental pharmaceutical
    products under certified Chinese Good Manufacturing Practice (CGMP) standards.

    About AMDL: More information about AMDL and its products can be obtained
    at http://www.amdl.com.

    Forward-Looking Statements

    This news release contains forward-looking statements within the meaning
    of the Private Securities Litigation Reform Act of 1995. Such statements are
    subject to certain risks and uncertainties, and actual circumstances, events
    or results may differ materially from those projected in such forward-looking
    statements. The Company cautions readers not to place undue reliance on any
    forward-looking statements. The Company does not undertake, and specifically
    disclaims any obligation, to update or revise such statements to reflect new
    circumstances or unanticipated events as they occur.

    Contact: AMDL, Inc.
    Mr. Paul Knopick
    AMDL Investor Relations
    Direct Line: 949.707.5365
    VoiceMail: 714.505.4460

    SOURCE AMDL, Inc.

  • 19Mar

    TORONTO, March 19 /PRNewswire/ — Redknee Solutions Inc. (”Redknee”)
    (AIM: RKN), a leading provider of innovative infrastructure software that
    monetizes and personalizes services and content for mobile operators, today
    announced that it has been selected by Cambodia Advance Communications
    (”CADCOMMS”) to provide Redknee’s Turnkey Converged Billing Solution. This
    multi-million dollar deal increases Redknee’s presence in the South East Asia
    market.

    As a new entrant in the highly competitive and emerging growth market in
    Cambodia, CADCOMMS saw that its opportunity to carve out a majority share of
    the market depended on its ability to differentiate itself with a flexible,
    personalized billing solution. CADCOMMS has selected Redknee’s Turnkey
    Converged Billing Solution to enable unique customer care operations with
    subscriber-centric, real-time rating, segmentation and promotion services for
    both prepaid and postpaid subscribers. The highly-flexible platform also
    helps the operator integrate new services and accelerate their time-to-market.
    The system provides self-care features that allow all subscribers to query and
    modify their attributes, reducing call center costs.

    “As we take our first steps into this market, we have a unique opportunity
    to clearly differentiate ourselves from existing telcos and to deliver
    transparent pricing models that provide more flexibility for our subscribers,”
    said Don Maclean, chief information officer at CADCOMMS. “After a thorough
    evaluation, we determined that the Redknee Turnkey Converged Billing platform
    provides the exceptional flexibility and scalability we require. The simple,
    open architecture of their solution promises ease of integration, swift
    deployment and scalability. Additionally, Redknee has established a strong
    Asian development and support infrastructure, and continuously demonstrates
    its commitment to working with CADCOMMS as a strategic, long-term partner.”

    Delivering a functionally-rich platform that extends beyond basic
    rating/charging/billing models, the Redknee Turnkey Converged Billing Solution
    for voice, data and messaging integrates easily with existing core network
    elements and offers out-of-the-box support for 3G+ services. The
    highly-scalable solution grows along with the subscriber base, allowing
    operators to meet demands for new service offerings and to stay ahead of
    increasing competition.

    “In the fiercely competitive environment of high-growth emerging mobile
    markets, the realization of subscriber and service revenue growth hinges on
    the operators’ capability to offer highly-personalized services,” said Lucas
    Skoczkowski, chief executive officer of Redknee. “CADCOMMS has taken a
    significant step toward establishing itself as a markedly-differentiated
    leader, uniquely positioned to realize increasing revenues and subscriber
    retention enabled by Redknee’s market leading solutions.”

    About CADCOMMS:

    Cambodia Advance Communication Co Ltd or “CADCOMMS” aims to be one of the
    leading telecommunication services providers in Cambodia. The company launched
    its services in March 2008. CADCOMMS operates a 3.5G HSPA mobile telephony
    service using the ‘qb’ brand under a license granted by the Ministry of Post
    and Telecommunication of Cambodia (MPTC).

    About Redknee:

    Redknee is a leading global provider of innovative communication software
    products, solutions and services. Redknee’s award-winning solutions enable
    operators to monetize the lifetime value of each subscriber transaction while
    personalizing the subscriber experience to meet mainstream, niche and
    individual market segment requirements. Redknee’s revenue generating solutions
    provide advanced converged billing, rating, charging and policy for voice,
    messaging and new generation data services to over 60 network operators in
    over 50 countries. Established in 1999, Redknee Solutions Inc. (AIM : RKN) is
    the parent of the wholly-owned operating subsidiary Redknee Inc. and its
    various subsidiaries. References to Redknee refer to the combined operations
    of those entities. For more information, please visit http://www.redknee.com.

    SOURCE Redknee Solutions Inc.

  • 14Feb

    PHNOM PENH, Cambodia, Feb. 14 /PRNewswire-USNewswire/ — AIDS Healthcare Foundation (AHF), which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, is honored to announce the partnership between the Cambodian Government and AHF and the start of its collaborative AIDS treatment center in Cambodia. The facility, AHF’s eighth in the country, was dedicated Monday, February 11th in Kirivong with a ribbon-cutting and dedication ceremony at the facility at the Kirivong Referral Hospital in Takeo Province. The Cambodian clinics are a partnership between AHF Cambodia Cares, the Ministry of Health, Royal Government of Cambodia and Cambodia’s National Center for HIV/AIDS, Dermatology and STI Control (NCHADS). The partnership aims to provide life-saving anti-retroviral therapy (ART) to people living with HIV/AIDS in Cambodia in care centers in the Operational Districts (OD) of several provinces throughout the country. Other ART centers in the partnership in Cambodia include sites in Phnom Penh, and in the provinces of Kandal, Kampong Thom, Kampot, Prey Veng, Stung Treng and Svay Rieng.

    “We are honored to open our eighth collaborative ART center in partnership with the Cambodian Ministry of Health and NCHADS at Kirivong, in Takeo Province, a facility which will bring relief, positive changes, better quality life and above all, hope of life to those in need in the surrounding area,” said Dr. Chinkholal Thangsing, Asia Pacific Bureau Chief for AIDS Healthcare Foundation. “Over the next five years, we will work together to expand and increase our collaborative initiatives in Cambodia, and AHF will continue to provide technical support and strengthen the roll out of antiretroviral treatment and the scale up of ART delivery services in Cambodia. It is our sincere hope that this collaboration between AHF and NCHADS will not only improve access to HIV/AIDS care and treatment throughout the country, but also serve as a shining example of a comprehensive and collaborative model of care for people living with HIV/AIDS.”

    One key aspect contributing to the success of AHF’s work with its partners in Cambodia includes the linkage of clinic services provided together with other community and home-based services. In addition, the Cambodian partnership focuses on integrating the delivery of services under a Continuum of Care (CoC) approach — an approach that recognizes the complexities surrounding the HIV/AIDS epidemic in order to improve prevention efforts and optimize use of the oftentimes limited resources available in the successful care and treatment of those living with the disease.

    Background on Takeo Province
    Takeo Province, one of 20 provinces in Cambodia, is located in southwestern Cambodia about 130 kms from Phnom Penh. Kirivong serves as one of the ten Operational Health Districts (OD) of the province, where the population of the surrounding area is approximately 226,000 people. The Kirivong Operational District has one Referral Hospital and 19 Health Centers.

    The ART Clinic, located at Kirivong Referral Hospital, was established in October 2005 by NCHADS and was supported by Europe Aid working with NCHADS from October 2005 to October 2007. At that time, Europe Aid ended its support to this clinic and NCHADS was left with no option but to seek support from elsewhere otherwise risk closing of the center.

    “It was then that NCHADS contacted AHF Cambodia Cares to provide support for continuance of support to the ART Center. AHF Cambodia Cares started its partial support to the Kirivong Continuum of Care site in October, and began fully supporting it from January 2008 onward. This collaborative support provided by AHF Cambodia Cares to NCHADS will ensure treatment, care and support to hundreds of clients on ART will continue to receive the life saving medications without interruption,” said Dr. Chhim Sarath, AIDS Healthcare Foundation’s Country Program Manager for Cambodia. “The center will not only support and provide continued services to existing clients, but will also ensure rapid scale up of the lifesaving treatment to many more PLHAs in Kirivong.”

    Currently there are 336 clients at the Kirivong site on treatment and care and 181 clients on antiretroviral treatment. The objectives of this collaboration at Kirivong are similar to the partnerships’ other projects throughout Cambodia, and include:

    – Capacity and skill building of the doctors and healthcare providers at the Kirivong Referral Hospital in collaboration with NCHADS, and
    – Establishment of an ART Clinic at the hospital and provision of free antiretroviral treatment to people living with HIV/AIDS (PLHA), including treatment of both adults and children.

    HIV/AIDS in Cambodia
    The first case of HIV infection in Cambodia was reported in 1991 and was followed by a rapid rise in its transmission. Cambodia’s national HIV/AIDS prevalence rate - around 3% in 1997 but decreasing to 1.9% in 2003 - is still understood to be one of the highest in Southeast Asia. According to a recent AFP/France 24 News Report (as cited on Kaiser Family Foundation’s Daily HIV/AIDS Report), “Almost 10,000 Cambodians die of AIDS-related illnesses annually, according to government statistics. About 1.9% of Cambodia’s 13.8 million people are HIV-positive.”

    “It is a privilege for AHF to continue to be a part of this successful AIDS treatment effort in Cambodia, and I thank our partners at the Ministry of Health, Dr. Mean Chhi Vun and his team at NCHADS, as well as our own dedicated staff at AHF’s Asia Pacific Bureau for helping to make widespread treatment availability more and more a reality in Cambodia,” said Michael Weinstein, President of AIDS Healthcare Foundation.

    About AHF
    AIDS Healthcare Foundation (AHF) is the US’ largest non-profit HIV/AIDS healthcare, research, prevention and education provider. AHF currently provides treatment, care and support services to more than 62,000 individuals in 20 countries worldwide in the US, Africa, Latin America/Caribbean and Asia. Additional information is available at www.aidshealth.org.

    SOURCE AIDS Healthcare Foundation

« Previous Entries